HDL: the metabolism, function, and therapeutic importance.
Wang
Minghan
M
Department of Cardiovascular and Metabolic Diseases, Pharmacia Corporation, 800 North Lindbergh Boulevard, St Louis, Missouri 63167, USA. mwang@amgen.com
Briggs
Michael R
MR
D018528:ATP-Binding Cassette Transporters / Q000378:metabolism; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D016632:Apolipoprotein A-I / Q000494:pharmacology; D018955:CD36 Antigens / Q000502:physiology; D002352:Carrier Proteins / Q000037:antagonists & inhibitors; D002784:Cholesterol / Q000378:metabolism; D053480:Cholesterol Ester Transfer Proteins; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000453:epidemiology; D006023:Glycoproteins; D006801:Humans; D006943:Hyperglycemia / Q000628:therapy; D008049:Lipase / Q000378:metabolism; D008075:Lipoproteins, HDL / Q000378:metabolism / Q000502:physiology* / Q000627:therapeutic use; D008565:Membrane Proteins; D051379:Mice; D009525:Niacin / Q000627:therapeutic use; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D014157:Transcription Factors / Q000819:agonists
D018528:ATP-Binding Cassette Transporters; D000924:Anticholesteremic Agents; D016632:Apolipoprotein A-I; D018955:CD36 Antigens; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D006023:Glycoproteins; D008075:Lipoproteins, HDL; D008565:Membrane Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; D014157:Transcription Factors; D009525:Niacin; D002784:Cholesterol; D007862:Phosphatidylcholine-Sterol O-Acyltransferase; C410382:LIPG protein, human; D008049:Lipase; C498741:Lipg protein, mouse